ArticleJAC-antimicrobial resistance2023

Assessing clinical cure of empirical piperacillin/tazobactam for ESBL urinary tract infections (ACCEPT-UTI).

Sylvia S Stefanos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.